90,300€
0,33%
Echtzeit-Aktienkurs Novartis AG (ADRs)
Bid:
Ask:
Echtzeit-Chart der Novartis AG (ADRs) Aktie
Börsenkurse Novartis AG (ADRs)
| New York | - | - | - | - | 98,130$ | 0,00% |
| Lang & Schwarz | - | - | - | - | 90,300€ | -0,22% |
| gettex | - | - | - | - | 90,300€ | 0,11% |
| Tradegate | - | - | - | - | 90,300€ | 0,22% |
| Bats USA | - | - | - | - | - | - |
| Echtzeit Euro | - | - | - | - | 90,300€ | 0,33% |
| Echtzeit USD | - | - | - | - | 98,232$ | 0,10% |
| Börse Frankfurt | - | - | - | - | 90,400€ | 2,73% |
| Börse Stuttgart | - | - | - | - | 90,300€ | 0,56% |
Fundamentaldaten der Novartis AG (ADRs) Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2022 [USD] | 50,55 Mrd. | 8,38 Mrd. | 6,96 Mrd. | 3,19 | 2,52% | 28,32 | 3,79 |
| 2021 [USD] | 51,63 Mrd. | 10,80 Mrd. | 24,02 Mrd. | 10,71 | 2,39% | 8,43 | 3,91 |
| 2020 [USD] | 48,66 Mrd. | 9,21 Mrd. | 8,07 Mrd. | 3,55 | 2,30% | 25,47 | 4,19 |
| 2019 [USD] | 47,50 Mrd. | 8,28 Mrd. | 7,04 Mrd. | 3,07 | 2,22% | 29,38 | 4,31 |
| 2018 [USD] | 51,90 Mrd. | 7,40 Mrd. | 12,61 Mrd. | 5,44 | 2,04% | 16,61 | 4,02 |
| 2017 [USD] | 49,11 Mrd. | 7,89 Mrd. | 7,70 Mrd. | 3,28 | 2,76% | 27,53 | 4,26 |
| 2016 [USD] | 48,52 Mrd. | 7,11 Mrd. | 6,71 Mrd. | 2,82 | 2,55% | 32,02 | 4,42 |
| 2015 [USD] | 49,44 Mrd. | 7,87 Mrd. | 17,78 Mrd. | 7,40 | 2,55% | 12,20 | 4,34 |
| 2014 [USD] | 52,42 Mrd. | 10,35 Mrd. | 10,21 Mrd. | 4,21 | 2,50% | 21,45 | 4,13 |
| 2013 [USD] | 57,92 Mrd. | 10,14 Mrd. | 9,18 Mrd. | 3,76 | 2,59% | 24,02 | 3,78 |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. | |||||||
Profil der Novartis AG (ADRs) Aktie
Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.